Atlas Trials

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

Clinical trial NCT00161200 · TERMINATED

Trial details

NCT number
NCT00161200
Sponsor
University of Medicine and Dentistry of New Jersey
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Esophageal Metaplasia
Start date
2002-12-01
Primary completion
2006-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.